Paul Denslow

Paul Denslow is an accomplished professional with extensive experience in the finance and biotech sectors. Currently, Paul serves as Board Chair, CEO, and Co-Founder at Intus Bio, and holds multiple advisory roles at Modulo Bio, CytoVeris, and Quidient. As the Founder of Canford Partners, Paul focuses on investing, syndication, consultancy, and fundraising in biotechnology and technology. Previously, Paul held senior positions at Standard Chartered Bank as Managing Director and Head of FX for the Americas, and at HSBC as Senior Vice President of FX Sales. Paul also gained valuable experience during an internship with KPMG UK and in equity capital markets at HSBC. Paul Denslow holds a Bachelor of Science degree in Economics from the University of Bath.